title: Clinical relevance of MDM2 SNP 309 and TP53 Arg72Pro in follicular lymphoma.
authors.forename: David
authors.initials: D
authors.lastname: Wrench
authors.forename: Rachel
authors.initials: R
authors.lastname: Waters
authors.forename: Emanuela
authors.initials: E
authors.lastname: Carlotti
authors.forename: Sameena
authors.initials: S
authors.lastname: Iqbal
authors.forename: Janet
authors.initials: J
authors.lastname: Matthews
authors.forename: Marie
authors.initials: M
authors.lastname: Calaminici
authors.forename: John
authors.initials: J
authors.lastname: Gribben
authors.forename: T Andrew
authors.initials: TA
authors.lastname: Lister
authors.forename: Jude
authors.initials: J
authors.lastname: Fitzgibbon
mesh_terms: D001120:Arginine / Q000235:genetics / Q000378:metabolism; D018450:Disease Progression; D005260:Female; D006801:Humans; D008224:Lymphoma, Follicular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009154:Mutation / Q000235:genetics; D009367:Neoplasm Staging; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D051736:Proto-Oncogene Proteins c-mdm2 / Q000235:genetics* / Q000378:metabolism; D015996:Survival Rate; D016159:Tumor Suppressor Protein p53 / Q000235:genetics* / Q000378:metabolism
chemical_list: C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53; D001120:Arginine; C497206:MDM2 protein, human; D051736:Proto-Oncogene Proteins c-mdm2